iMDx Financial Results Announcement and Upcoming Conference
Insight Molecular Diagnostics, also known as iMDx (NASDAQ: IMDX), is set to announce its second quarter financial results for 2025 after the market closes on August 11. On that date, the company will also host a live Zoom webinar at 2:00 PM PT/5:00 PM ET for a detailed discussion of these results.
Details of the Financial Webinar
During this webinar, iMDx will provide insights into its financial performance, preceded by a Q&A session allowing stakeholders to engage directly with the management team. Interested participants can register for the webinar, which aims to foster transparency and open dialogue regarding the company's financial standing.
Needham Virtual MedTech & Diagnostics Conference Participation
On August 12, iMDx's Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will be participating in the 10th Annual Needham Virtual MedTech and Diagnostics Conference. This engagement provides the company with an excellent opportunity to showcase its innovations to investors and industry experts. Investors are encouraged to book one-on-one meetings with the management team during this event through their Needham sales representatives.
Conference Details
Event: 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
Dates: August 11-12, 2025
Format: Virtual
About Insight Molecular Diagnostics Inc.
iMDx, previously known as Oncocyte Corp. (OCX), specializes in advanced diagnostics technology. The company is dedicated to democratizing access to cutting-edge molecular diagnostic tests designed to significantly enhance patient outcomes. Through continuous innovation, iMDx works towards improving the accessibility and effectiveness of diagnostic testing.
Recent Developments in Molecular Diagnostics
In June 2025, the company moved its headquarters from Irvine, California, to Nashville, Tennessee, marking a significant step in its growth strategy. Along with the relocation, iMDx adopted a new NASDAQ trading symbol which became effective shortly thereafter. This move is anticipated to better position iMDx in the competitive diagnostics market and attract more investors.
Investor Relations at iMDx
Investors looking for more information about iMDx's financial health, product offerings, and future events can visit the company’s investor relations website. This platform provides valuable insights and updates to stakeholders.
Contact Information
If you have any inquiries regarding the company’s financial performance or upcoming events, feel free to contact their investor relations representative:
Doug Farrell
LifeSci Advisors LLC
Email: dfarrell@lifesciadvisors.com
Frequently Asked Questions
What is the date for iMDx's second quarter financial results release?
iMDx will report its second quarter financial results on August 11, 2025.
How can I access the iMDx financial results webinar?
The webinar can be accessed by registering through the official link provided by iMDx, which will be available closer to the event date.
Who from iMDx will be attending the Needham Conference?
CEO Josh Riggs and CFO Andrea James will represent iMDx at the conference.
What are the dates for the Needham Virtual MedTech Conference?
The conference is scheduled for August 11-12, 2025.
How has iMDx been evolving as a company?
iMDx has relocated its headquarters and changed its NASDAQ symbol, indicating a proactive strategy to enhance its market presence and investor relationships.